GRACE II (General Retrospective Analysis of Commercial Experience With AGN1 LOEP)
GRACE II (General Retrospective Analysis of Commercial Experience With AGN1 LOEP)
Not yet recruiting · NCT07594639 · Registry updated 2026-05-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GRACE II (General Retrospective Analysis of Commercial Experience With AGN1 LOEP) | Bone Diseases, Developmental, Bone Diseases, Metabolic, Collagen Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Femoral Fractures, Hip Injuries, Leg Injuries, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, bone disorder, bone fracture, connective tissue disorder, hereditary disease, hip fracture, hypophosphatasia, inborn errors of metabolism, inborn metal metabolism disorder, injury, metabolic disease, musculoskeletal system disorder, osteochondrodysplasia, osteogenesis imperfecta, osteoporosis | Not yet recruiting | Not stated | 2026-05-19 | NCT07594639 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AgNovos Healthcare, LLC | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Vitaz | Sint-Niklaas | Belgium | 11 |